Clinical Trials List
Protocol NumberCWNT974X2102C
2016-02-12 - 2018-01-15
Phase I/II
Terminated1
ICD-9154.1
Malignant neoplasm of rectum
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林育麟 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
40 participants
